- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological management of COVID-19 in type 2 diabetes
Authors
Keywords
ACE2, Cardiovascular disease, Corticosteroids, COVID-19, Diabetes, Guidelines, Hydroxychloroquine, Hyperglycemia, SARS-COV-2, Thrombosis
Journal
JOURNAL OF DIABETES AND ITS COMPLICATIONS
Volume -, Issue -, Pages 107927
Publisher
Elsevier BV
Online
2021-04-19
DOI
10.1016/j.jdiacomp.2021.107927
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection
- (2021) Myron S. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
- (2021) Eduardo López-Medina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis
- (2021) Stephen A. Klassen et al. MAYO CLINIC PROCEEDINGS
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
- (2020) Dominic Wichmann et al. ANNALS OF INTERNAL MEDICINE
- A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
- (2020) Krishna Sriram et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes
- (2020) Massimiliano Bonafè et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
- (2020) Antonio Ceriello et al. DIABETES CARE
- Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
- (2020) Celestino Sardu et al. DIABETES CARE
- Why is hyperglycemia worsening COVID ‐19 and its prognosis?
- (2020) Antonio Ceriello et al. DIABETES OBESITY & METABOLISM
- Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes
- (2020) Francesco Prattichizzo et al. DIABETES OBESITY & METABOLISM
- COVID-19, diabetes mellitus and ACE2: The conundrum
- (2020) Rimesh Pal et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
- (2020) Rimesh Pal et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
- (2020) Xiaochen Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
- (2020) Ishan Paranjpe et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
- (2020) Sebastiano Bruno Solerte et al. ACTA DIABETOLOGICA
- COVID-19–Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis
- (2020) Md Saiful Islam et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Issues for the management of people with diabetes and COVID-19 in ICU
- (2020) Antonio Ceriello et al. Cardiovascular Diabetology
- Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019
- (2020) Shivani Agarwal et al. DIABETES CARE
- Hydroxychloroquine, COVID ‐19 and diabetes. Why it is a different story
- (2020) Anca Pantea Stoian et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Convalescent plasma a clutch at straws in COVID‐19 management! A systematic review and meta‐analysis
- (2020) Soumya Sarkar et al. JOURNAL OF MEDICAL VIROLOGY
- Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection
- (2020) Anuradha Lala et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) Mandeep R Mehra et al. LANCET
- Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists
- (2020) Fiorella Calabrese et al. VIRCHOWS ARCHIV
- The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID ‐19
- (2020) Zihui Xu et al. Journal of Diabetes
- Practical recommendations for the management of diabetes in patients with COVID-19
- (2020) Stefan R Bornstein et al. Lancet Diabetes & Endocrinology
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
- (2020) Naomi Holman et al. Lancet Diabetes & Endocrinology
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
- (2020) Yujun Tang et al. Frontiers in Immunology
- Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study
- (2020) Jianfeng Wu et al. BMJ Open Diabetes Research & Care
- Steroids in COVID-19: An overview
- (2020) Kshitij Chatterjee et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
- (2020) Sebastiano Bruno Solerte et al. DIABETES CARE
- Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
- (2020) Marco Mirani et al. DIABETES CARE
- Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration
- (2020) Gian Paolo Fadini et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19
- (2020) Andrea Cortegiani et al. JOURNAL OF CRITICAL CARE
- COVID-19 in people living with diabetes: An international consensus
- (2020) A.E. Caballero et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
- (2020) Wesley H. Self et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical outcomes for COVID‐19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China
- (2020) Wei Dai et al. JOURNAL OF MEDICAL VIROLOGY
- Type 2 Diabetes: How Much of an Autoimmune Disease?
- (2019) Paola de Candia et al. Frontiers in Endocrinology
- Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention
- (2019) Annunziata Nusca et al. Cardiovascular Diabetology
- Targets for blood glucose: What have the trials told us
- (2019) Paul Valensi et al. European Journal of Preventive Cardiology
- Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
- (2019) Francesco Prattichizzo et al. European Journal of Preventive Cardiology
- Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications
- (2019) Elisa Dal Canto et al. European Journal of Preventive Cardiology
- Coagulatory Defects in Type-1 and Type-2 Diabetes
- (2019) Amélie I. S. Sobczak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of multiple glycemic parameters at intensive care unit admission with mortality and clinical outcomes in critically ill patients
- (2019) Priscila Bellaver et al. Scientific Reports
- Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
- (2016) Rena M. Pollack et al. DIABETES CARE
- 13. Diabetes Care in the Hospital: Table 13.1
- (2015) DIABETES CARE
- Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes
- (2015) Wen-I. Liao et al. MEDICINE
- The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism
- (2013) Lihua Jin et al. Nature Communications
- Hyperglycemia: a prothrombotic factor?
- (2010) B. A. LEMKES et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Lowering Glucose to Prevent Adverse Cardiovascular Outcomes in a Critical Care Setting
- (2009) Antonio Ceriello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More